Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis

Pasquale Abete1, David Della-Morte2, Gaetano Gargiulo3

  • 1Department of Translational Medical Sciences, University of Naples "Federico II", Italy.

Ageing Research Reviews
|August 10, 2014
PubMed

Insights

Cardiovascular diseases like hypertension and heart failure increase dementia risk. This review examines studies linking various heart conditions to cognitive decline and dementia progression.

Area of Science:

  • Cardiology
  • Neurology
  • Geriatrics

Background:

  • Aging populations face rising rates of cardiovascular diseases (CVDs), including hypertension, coronary artery disease, atrial fibrillation, and chronic heart failure.
  • Growing evidence links CVDs to an elevated risk of cognitive impairment and dementia, potentially via mechanisms like embolic stroke or chronic cerebral hypoperfusion.

Purpose of the Study:

  • To review existing literature on the association between cardiovascular diseases and the presence or development of cognitive impairments and dementia.
  • To synthesize findings regarding the spectrum of cardiovascular conditions and their impact on cognitive function.

Main Methods:

  • Systematic literature review of cohort studies and observational research.
  • Analysis of studies investigating cognitive function and dementia in patients with diverse cardiovascular conditions.

Main Results:

  • Studies indicate a significant relationship between cardiovascular diseases and increased risk for cognitive impairment.
  • Evidence suggests a potential continuum from conditions like hypertension and atrial fibrillation to cognitive decline and dementia progression.

Conclusions:

  • Cardiovascular diseases represent a significant risk factor for cognitive impairment and dementia.
  • A hypothesized continuum exists among hypertension, coronary artery disease, atrial fibrillation, and chronic heart failure, contributing to cognitive impairment and dementia development.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
392
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
365
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K